Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03031795Phase 4Completed
Phase 4, randomised, double-blind trial of ketorolac, sponsored by OhioHealth. Primary endpoint: Pain Before, During and After IUD Placement. Started Jul 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03031795.